SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001013594-23-000249
Filing Date
2023-02-14
Accepted
2023-02-14 16:15:38
Documents
1

Document Format Files

Seq Description Document Type Size
1 marinussc13ga3-021423.htm SC 13G/A 147445
  Complete submission text file 0001013594-23-000249.txt   149120
Mailing Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087
Business Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087 484-801-4670
MARINUS PHARMACEUTICALS, INC. (Subject) CIK: 0001267813 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88269 | Film No.: 23629504
SIC: 2834 Pharmaceutical Preparations

Mailing Address 250 WEST 55TH STREET 33RD FLOOR NEW YORK NY 10019
Business Address 250 WEST 55TH STREET 33RD FLOOR NEW YORK NY 10019 212-356-6200
Lion Point Capital, LP (Filed by) CIK: 0001643354 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1230
Type: SC 13G/A